v3.25.4
Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023   19,775,041      
Beginning balance at Dec. 31, 2023 $ 156,195 $ 20 $ 450,945 $ (24,437) $ (270,333)
Beginning balance (in shares) at Dec. 31, 2023         5,571,004
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (22,300)     (22,300)  
Stock-based compensation 1,973   1,973    
Restricted stock issued (in shares)   22,577      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         1,607
Restricted stock surrendered for employee tax payment (64)       $ (64)
Shares issued for director stipends (in shares)   1,559      
Shares issued for director stipends 37   37    
Ending balance (in shares) at Mar. 31, 2024   19,799,177      
Ending balance at Mar. 31, 2024 135,841 $ 20 452,955 (46,737) $ (270,397)
Ending balance (in shares) at Mar. 31, 2024         5,572,611
Beginning balance (in shares) at Dec. 31, 2023   19,775,041      
Beginning balance at Dec. 31, 2023 156,195 $ 20 450,945 (24,437) $ (270,333)
Beginning balance (in shares) at Dec. 31, 2023         5,571,004
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (151,184)        
Ending balance (in shares) at Jun. 30, 2024   19,814,005      
Ending balance at Jun. 30, 2024 9,515 $ 20 455,185 (175,621) $ (270,069)
Ending balance (in shares) at Jun. 30, 2024         5,558,519
Beginning balance (in shares) at Mar. 31, 2024   19,799,177      
Beginning balance at Mar. 31, 2024 135,841 $ 20 452,955 (46,737) $ (270,397)
Beginning balance (in shares) at Mar. 31, 2024         5,572,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (128,884)     (128,884)  
Stock-based compensation 2,159   2,159    
Restricted stock issued (in shares)   13,947      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         3,706
Restricted stock surrendered for employee tax payment (92)       $ (92)
Shares issued for director stipends (in shares)   881      
Shares issued for director stipends 23   23    
Shares issued for ESPP 468   48   $ 420
Shares issued for ESPP (in shares)         (17,798)
Ending balance (in shares) at Jun. 30, 2024   19,814,005      
Ending balance at Jun. 30, 2024 $ 9,515 $ 20 455,185 (175,621) $ (270,069)
Ending balance (in shares) at Jun. 30, 2024         5,558,519
Beginning balance (in shares) at Dec. 31, 2024 19,882,026 19,882,026      
Beginning balance at Dec. 31, 2024 $ (38,474) $ 20 457,406 (225,715) $ (270,185)
Beginning balance (in shares) at Dec. 31, 2024 5,558,898       5,558,898
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (50,377)     (50,377)  
Stock-based compensation 1,217   1,217    
Restricted stock issued (in shares)   35,083      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         9,103
Restricted stock surrendered for employee tax payment 1       $ 1
Ending balance (in shares) at Mar. 31, 2025   19,917,109      
Ending balance at Mar. 31, 2025 $ (87,633) $ 20 458,623 (276,092) $ (270,184)
Ending balance (in shares) at Mar. 31, 2025         5,568,001
Beginning balance (in shares) at Dec. 31, 2024 19,882,026 19,882,026      
Beginning balance at Dec. 31, 2024 $ (38,474) $ 20 457,406 (225,715) $ (270,185)
Beginning balance (in shares) at Dec. 31, 2024 5,558,898       5,558,898
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (354,066)        
Ending balance (in shares) at Jun. 30, 2025 19,923,878 19,923,878      
Ending balance at Jun. 30, 2025 $ (391,637) $ 20 457,245 (579,781) $ (269,121)
Ending balance (in shares) at Jun. 30, 2025 5,524,734       5,524,734
Beginning balance (in shares) at Mar. 31, 2025   19,917,109      
Beginning balance at Mar. 31, 2025 $ (87,633) $ 20 458,623 (276,092) $ (270,184)
Beginning balance (in shares) at Mar. 31, 2025         5,568,001
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (303,689)     (303,689)  
Stock-based compensation (442)   (442)    
Restricted stock issued (in shares)   6,769      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         2,038
Restricted stock surrendered for employee tax payment (3)       $ (3)
Shares issued for ESPP $ 130   (936)   $ 1,066
Shares issued for ESPP (in shares)         (45,305)
Ending balance (in shares) at Jun. 30, 2025 19,923,878 19,923,878      
Ending balance at Jun. 30, 2025 $ (391,637) $ 20 $ 457,245 $ (579,781) $ (269,121)
Ending balance (in shares) at Jun. 30, 2025 5,524,734       5,524,734